European Respiratory Society (ERS) 2024

September 7, 2024
September 11, 2024
CET
RX Wien GmbH. Messeplatz 1, Postfach 277 A-1021 Vienna, Austria

The European Respiratory Society (ERS) Congress is an annual event that brings together the world’s respiratory experts to showcase all the latest advances in respiratory medicine and science.

Stop by the Clario Booth #B6.01 to speak with our experts and find out what’s new for your respiratory clinical trials!

Poster session information:

PS-14: Monitoring in airway disease I: looking towards the future

Poster Session: AI-Based Quality Assessment of Peak Expiratory Flow in Spirometry

Date: Sunday, September 8

Time: 8:00 – 9:30 CET

Authors:

  • Benoit Cuyvers – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Maarten De Vos – R&D Advisor at ArtiQ NV, a Clario Company
  • Paul Desbordes – AI Scientist at ArtiQ NV, a Clario Company
  • Diana Teixeira E Silva – AI Scientist at ArtiQ NV, a Clario Company
  • Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

A1 Oral presentation topic: Enhancing respiratory care with technology and improving effectiveness of smoking cessation programme

Oral poster title: Late Breaking Abstract – SPIROmetry interpretation in primary care with or without Artificial Intelligence Decision support software (SPIRO-AID) – led by Prof. William Man, Professor of Respiratory Medicine, Royal Brompton & Harefield Hospitals

Date: Sunday, September 8

Time: 10:15 – 11:45 CET

Authors:

  • Karolien Van Orshoven – Lead Project Manager at ArtiQ NV, a Clario Company
  • Maarten De Vos – R&D Advisor at ArtiQ NV, a Clario Company
  • Ahmed Elmahy – AI Scientist at ArtiQ NV, a Clario Company
  • Benoit Cuyvers – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Paul Desbordes – AI Scientist at ArtiQ NV, a Clario Company
  • Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

A1 Oral presentation topic: Man and machine: getting the balance right from innovation to implementation

Oral poster title: Identification of COPD from primary care spirometry with artificial intelligence (AI) interpretation software: a retrospective, diagnostic accuracy study – led by Prof. William Man, Professor of Respiratory Medicine, Royal Brompton & Harefield Hospitals

Date: Sunday, September 8

Time: 11:00 – 12:15 CET

Authors:

  • Karolien Van Orshoven – Lead Project Manager at ArtiQ NV, a Clario Company
  • Maarten De Vos – R&D Advisor at ArtiQ NV, a Clario Company
  • Ahmed Elmahy – AI Scientist at ArtiQ NV, a Clario Company
  • Benoit Cuyvers – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Paul Desbordes – AI Scientist at ArtiQ NV, a Clario Company
  • Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

PS-20: Pulmonary function tests: advanced technology and improved quality control for better patient care

Poster Session: Detection of a common method for undermining the evaluation of full inflation in a clinical trial for asthma

Date: Monday, September 9

Time: 8:00 – 9:30 CET

Authors:

  • Kevin McCarthy – Director, Respiratory Science at Clario
  • Phil Lake, Ph.D. – Senior Director, Respiratory Solutions at Clario

PS-27: Looking for biomarkers in interstitial lung disease of known origins

Poster Session: Big data insights in the ILD population through AI-driven analytics

Date: Monday, September 9

Time: 8:00 – 9:30 CET

Authors:

  • Ahmed Elmahy – AI Scientist at ArtiQ NV, a Clario Company
  • Maarten De Vos – R&D Advisor at ArtiQ NV, a Clario Company
  • Julie Maes – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Elena Smets – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

PS-14: Monitoring in airway disease II: looking towards the future

Poster Session: AI model generalization assessed on unlabeled pulmonary function data from daily use

Date: Monday, September 9

Time: 12:30 – 14:00 CET

Authors:

  • Ahmed Elmahy – AI Scientist at ArtiQ NV, a Clario Company
  • Maarten De Vo – R&D Advisor at ArtiQ NV, a Clario Company
  • Julie Maes – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Elena Smets – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

PS-14: Monitoring in airway disease II: looking towards the future

Poster Session: Home Spirometry in Clinical Trials: Evaluating Adherence and Quality in Patients with Asthma

Date: Monday, September 9

Time: 12:30 – 14:00 CET

Authors:

  • Benoit Cuyvers – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Paul Desbordes – AI Scientist at ArtiQ NV, a Clario Company
  • Karolien Van Orshoven – Lead Project Manager at ArtiQ NV, a Clario Company
  • Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

PS-3: A primary care approach to chronic obstructive pulmonary disease

Poster Session: A case study on the impact of Artificial Intelligence supported spirometry in primary care

Date: Tuesday, September 10

Time: 8:00 – 9:30 CET

Authors:

  • Elena Smets – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Julie Maes – Upstream AI Product Manager at ArtiQ NV, a Clario Company
  • Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

Meet with us at European Respiratory Society (ERS) 2024.

Complete this form and we will reach out soon to schedule a time to connect at the event.

If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.